Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
We measured FGF-23 in only two patients; both patients had abnormally increased FGF-23 values that were specifically suggestive of TIO.Patient characteristics.SexAgeDuration (years)P (2.5 to 4.5 mg/dL)Ca (8.6 to 10.2 mg/dL)ALP (40 to 120 IU/L)Cr (0.7 to 1.4 mg/dL)PTH (10 to 65 pg/mL)FGF23 (> 180 RU/mL)TRP (> 85%)25 (OH)D (8.0 to 51.9 ng/mL)1.25 (OH)2D (19.6 to 54.3 pg/mL)MRI/CT18F-FDG PET68Ga-DOTATOC PET detection (FOV)Lesion (SUV)Longest diameter (cm)PathologySurgeryName of surgery1F7421.01.68.96670.5055.6x78/8310.821.8xxPositive (W)Maxilla (12.7)1.8PositiveOPartial maxillectomy2M542.02.18.61830.9551.3x78/82xxOOPositive (W)Groin (24.0)1.1PositiveOLymph node excision3F7112.11.48.94070.51127.0x5748.9xOxPositive (W)Thigh (9.9)6.5PositiveOWide excision4F4711.21.08.51250.5071.6x84/8056.6xOxPositive (W)Fibula (1.9)1.6PositiveOResection of fibular head5M532.12.48.8910.8741.7x83/8219.6xOxPositive (T)L3 (4.5)1.4PositiveOPartial corpectomy and bone graft6F602.30.98.71970.4426.6412x23.012.5OOPositive (W)C2 (10.7)2.8PositiveOCurettage and bone graft7F4818.81.58.33610.9056.73740672.4xOxPositive (W)Femur (45.7)4.2Positivexx8M707.32.19.22050.8026.6x7021.07.0OOPositive (W)Pubic (12.2)2.1xxx9F638.32.19.01681.129.8xx35.639.7OxNegative (W)xxxxx10F608.31.87.0840.40153.0x90/871.5xOxNegative (T)xxxxx11F486.51.18.81690.8378.1x74/723.511.1OONegative (W)xxxxx12M783.91.68.52830.6454.8x82/7928.714.1OONegative (T)xxxxxP phosphorous, Ca calcium, ALP alkaline phosphatase, Cr creatinine, PTH parathyroid hormone, FGF-23 fibroblast growth factor-23, TRP tubular reabsorption of phosphate, 25(OH)D 25-hydroxyvitamin D,1,25(OH)2D,1,25-dihydroxyvitamin D, MRI magnetic resonance imaging, CT computed tomography, 18F-FDG 18Fluoride-Fluorodeoxyglucose, PET positron emission tomography, 68Ga-DOTATOC PET/CT 68Ga-labeled DOTA0-Tyr3 octreotide (DOTATOC), FOV field of view, SUV standardized uptake value, F female, M male, W whole body, T Torso, C2 2nd cervical spine, L3 3rd lumbar spine.
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study protocol.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
2019-1290) approved this study protocol and waived informed consent from patients due to the retrospective nature of the study.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Usefulness of 68Ga-DOTATOC PET/CT to localize the culprit tumor inducing osteomalacia
Study protocol · Scientific Reports · 2021
Original publication title
Usefulness of 68Ga-DOTATOC PET/CT to localize the culprit tumor inducing osteomalacia
© The Author(s) 2021
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Tumor-induced osteomalacia (TIO) is an uncommon paraneoplastic syndrome presenting with sustained hypophosphatemia. Treatment of choice is removal of the tumor causing the TIO, but identification of the culprit tumor by routine imaging is challenging. This study aimed to assess the usefulness of somatostatin receptor imaging, called 68Ga-DOTATOC PET/CT, in the management of patients with TIO. Twelve patients who were suspected of having TIO underwent 68Ga-DOTATOC PET/CT. Lesion detectability and maximum standardized uptake value (SUVmax) were determined and retrospectively compared with the clinical/imaging surveillance and histopathologic diagnosis.
The median duration of suspected TIO with hypophosphatemia was 7.8 years (range 2.1 to 21.0). Conventional radiologic and/or nuclear medicine images failed to identify the culprit tumors. However, 68Ga-DOTATOC PET/CT scans showed that 8 of the 12 patients had positive lesions, suggesting the presence of focal culprit tumors. The SUVmax of positive tumors was 1.9 to 45.7 (median: 11.5). Six skeletal lesions and two extra-skeletal lesions were identified. Seven of the lesions were pathologically confirmed as potential culprits of TIO. Hypophosphatemia was resolved in five patients who underwent lesion excision.
The 68Ga-DOTATOC PET/CT is a useful whole-body imaging modality for the detection of causative tumors in patients with suspected TIO.
Authors’ abstract
Tumor-induced osteomalacia (TIO) is an uncommon paraneoplastic syndrome presenting with sustained hypophosphatemia. Treatment of choice is removal of the tumor causing the TIO, but identification of the culprit tumor by routine imaging is challenging. This study aimed to assess the usefulness of somatostatin receptor imaging, called 68Ga-DOTATOC PET/CT, in the management of patients with TIO. Twelve patients who were suspected of having TIO underwent 68Ga-DOTATOC PET/CT. Lesion detectability and maximum standardized uptake value (SUVmax) were determined and retrospectively compared with the clinical/imaging surveillance and histopathologic diagnosis.
The median duration of suspected TIO with hypophosphatemia was 7.8 years (range 2.1 to 21.0). Conventional radiologic and/or nuclear medicine images failed to identify the culprit tumors. However, 68Ga-DOTATOC PET/CT scans showed that 8 of the 12 patients had positive lesions, suggesting the presence of focal culprit tumors. The SUVmax of positive tumors was 1.9 to 45.7 (median: 11.5). Six skeletal lesions and two extra-skeletal lesions were identified. Seven of the lesions were pathologically confirmed as potential culprits of TIO. Hypophosphatemia was resolved in five patients who underwent lesion excision.
The 68Ga-DOTATOC PET/CT is a useful whole-body imaging modality for the detection of causative tumors in patients with suspected TIO.
Publication and source details
Original title: Usefulness of 68Ga-DOTATOC PET/CT to localize the culprit tumor inducing osteomalacia
Dong Yun Lee; Seung Hun Lee; Beom-Jun Kim; Wanlim Kim; Pil Whan Yoon; Sang Ju Lee; Seung Jun Oh; Jung-Min Koh; Jin-Sook Ryu
Scientific Reports · 2021
© The Author(s) 2021https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Ministry of HealthRepository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T13:35:07.944747+00:00
DOI: 10.1038/s41598-021-81491-2 · PMC7815743